+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "EU Clinical Trial Regulation"

From
From
From
Risk Based Monitoring for GCP Compliance - Webinar (Recorded) - Product Thumbnail Image

Risk Based Monitoring for GCP Compliance - Webinar (Recorded)

  • Webinar
  • March 2019
  • 90 Minutes
  • Global
  • 9 Results (Page 1 of 1)
Loading Indicator

The EU Clinical Trial Regulation market pertains to the landscape of clinical trials within member states of the European Union, which is governed by a framework designed to ensure the highest standards of safety and efficiency. The regulations establish a unified submission and assessment process for clinical trials across the EU, with an emphasis on transparency and harmonization. Under this system, there is a centralized EU portal and database for all clinical trial information, which is accessible to the public, regulatory authorities, and sponsors. This regulation fosters collaboration between EU countries, simplifying the cross-border conduct of clinical trials and aiming to advance medical research and development within the EU while maintaining ethical considerations and patient safety. Companies operating in the EU Clinical Trial Regulation market encompass a range of entities that provide various services related to the design, conduct, and management of clinical trials. Some of the firms in this space include IQVIA, a provider of biopharmaceutical development and commercial outsourcing services; ICON plc, a contract research organization (CRO) that offers clinical research services; PAREXEL International Corporation, specializing in providing clinical research and logistics services; and Covance, a CRO which provides drug development and life-cycle management services. Show Less Read more